The Problem Of Treating Patients With Heart Disease Who Do Not Respond To Plavix

The Problem Of Treating Patients With Heart Disease Who Do Not Respond To Plavix.
Higher doses of the blood-thinner Plavix were no better at preventing nitty-gritty attacks, blood clots or undoing than the archetype crop quantity in patients who had received artery-opening stents, new inquire into shows. The higher dose - false the usual amount - was tested in patients with "high platelet reactivity," sense they failed to respond to the drug at lower doses virilityex.herbalous.com. Plavix (clopidogrel) helps thwart clots from forming in patients who have glum platelet reactivity and who have had stents inserted to prop ice-free blocked arteries.

But the new study "doesn't support" physicians using the higher, 150-milligram administer of Plavix after stenting, according to analyse lead author Dr Matthew Price, who presented the findings Tuesday at the annual congress of the American Heart Association in Chicago. So, the inquiry leaves an important question unanswered: How to prescribe for heart patients who don't respond well to Plavix? "It remains vague to some extent," said Dr Abhiram Prasad, an interventional cardiologist with the Mayo Clinic in Rochester, Minn supplements. "It's an superior research to have done but the key issues are that a significant ration of the patients remained with high platelet reactivity even after being on the higher dose".

Previous, smaller studies had indicated that Plavix might have more of an accomplish if the measure was doubled. "Platelet reactivity varies widely," noted Price, captain of the Cardiac Catheterization Laboratory at the Scripps Clinic in La Jolla, Calif. He explained that numerous studies have shown that a exalted reactivity stage is associated with poorer outcomes after angioplasty and/or stenting. But until now, a abrupt rise in the dosage of Plavix "has not been tested in a large randomized clinical trial".

For this trial, investigators tested a portly group of patients for platelet reactivity after they had undergone angioplasty to associate a drug-eluting stent. Drug-eluting stents forth medicines that help dependant off vessel re-closure. Over 2200 patients with high platelet reactivity were then randomized to get 150 milligrams a day of Plavix or the defined 75-milligram dose.

After six months, 2,3 percent of those taking either the higher or the trim dose suffered heart attacks, efficient blood clots in their stents, or died, the researchers report. Those taking the higher amount of the blood-thinner didn't have any worse bleeding than those taking the footing dose, indicating that the higher dose of Plavix in this faction of patients wasn't any less safe. The study was sponsored by Accumetrics, which makes VerifyNow, a proof used to time platelet function.

The makers of Plavix, Sanofi-Aventis and Bristol-Myers Squibb provided the drug, and paramount investigator Price also disclosed ties with pharmaceutical companies. "The attempt does not support a care strategy of high dose clopidogrel in - patients with high-risk reactivity identified by a distinct platelet test". Still, Prasad said that higher jeopardy patient populations may privation to be studied before drawing any firm conclusions about dosing start vigrx plus top. "Or c peradventure we need a more potent drug".